++
For further information, see CMDT Part 17-01: Fibrocystic Condition
+++
Essentials of Diagnosis
++
Painful breast masses; often multiple and bilateral masses
Rapid fluctuation in mass size is common
Pain often worsens premenstrually
+++
General Considerations
++
Most frequent lesion of the breast
Estrogen hormone is considered a causative factor
Alcohol consumption may increase risk, especially in women aged 18–22 yrs
Encompasses a wide variety of benign histologic changes in the breast epithelium
Microscopic findings include
Only variants with component of epithelial proliferation (especially with atypia) or increased breast density on mammogram represent true risk factor for breast cancer
++
++
Generally painful mass or masses but may be asymptomatic
Serous nipple discharge may be present
Rapid fluctuation in size of masses is common
+++
Differential Diagnosis
++
Breast cancer
Fibroadenoma
Lipoma
Breast abscess
Intraductal papilloma
++
+++
Diagnostic Procedures
++
Suspicious lesions should be biopsied
Core needle biopsy, rather than fine-needle aspiration (FNA), is the preferable technique unless the lesion is cystic
Excisional biopsy is rarely necessary but should be done for lesions with atypia or where imaging and biopsy results are discordant
++
Gamolenic acid, 3 g orally twice daily
Vitamin E, 400 international units orally once daily (anecdotal data)
Danazol, 100–200 mg orally twice daily, for severe pain, but is rarely used due to side effects (acne, hirsutism, edema)
Tamoxifen reduces some symptoms but it is not useful in young women due to side effects, unless it is given to reduce risk of cancer
Postmenopausal women receiving hormone replacement therapy may stop hormones to reduce pain
++
+++
Therapeutic Procedures
++